Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: comparison with cationic antimicrobial peptides and lipopeptides

Biochimica Et Biophysica Acta
Suzana K Straus, Robert E W Hancock

Abstract

With the steady rise in the number of antibiotic-resistant Gram-positive pathogens, it has become increasingly important to find new antibacterial agents which are highly active and have novel and diversified mechanisms of action. Two classes will be discussed here: the cationic antimicrobial peptides, which are amphiphilic in nature, targeting membranes and increasing their permeability; and lipopeptides, which consist of linear or cyclic peptides with an N-terminus that is acylated with a fatty acid side chain. One member of the cyclic lipopeptide family, the anionic molecule daptomycin, has been extensively studied and is the major focus of this review. Models will be presented on its mode of action and comparisons will be made to the known modes of action of cationic antimicrobial peptides and other lipopeptides.

References

Jan 1, 1977·Annual Review of Biochemistry·D R StormP E Swanson
Feb 6, 1978·The Journal of Membrane Biology·I R MillerM Teuber
Jul 1, 1987·Antimicrobial Agents and Chemotherapy·N E AllenW E Alborn
Aug 1, 1987·The Journal of Antimicrobial Chemotherapy·J H AndrewD Greenwood
Oct 1, 1986·Antimicrobial Agents and Chemotherapy·G M EliopoulosR C Moellering
Nov 1, 1986·Antimicrobial Agents and Chemotherapy·R J Fass, V L Helsel
Feb 1, 1987·European Journal of Clinical Microbiology·R L HodinkaP H Gilligan
Feb 1, 1987·European Journal of Clinical Microbiology·F Ehlert, H C Neu
Oct 1, 1969·The Journal of Antibiotics·J Shoji, H Otsuka
Jan 1, 1968·The Journal of Antibiotics·H NaganawaT Takeushi
Nov 1, 1984·Canadian Journal of Biochemistry and Cell Biology = Revue Canadienne De Biochimie Et Biologie Cellulaire·R M Epand, W K Surewicz
Jan 8, 1998·The Journal of Antimicrobial Chemotherapy·D W Denning
May 29, 1999·Antimicrobial Agents and Chemotherapy·R E Hancock, D S Chapple
Jan 8, 2000·Biochemistry·W T HellerH W Huang
Jul 29, 2000·Biochemistry·H W Huang
Oct 6, 2000·The Journal of Antimicrobial Chemotherapy·F P Tally, M F DeBruin
Oct 12, 2000·Biophysical Journal·L YangH W Huang
May 17, 2001·Antimicrobial Agents and Chemotherapy·J A SilvermanT Li
May 17, 2001·Antimicrobial Agents and Chemotherapy·A L BarryS D Brown
Mar 2, 2002·The Lancet Infectious Diseases·R E Hancock
Apr 12, 2002·Current Pharmaceutical Design·Deirdre A Devine, Robert E W Hancock
Jun 1, 2002·The Journal of Antimicrobial Chemotherapy·David W Denning
Jul 19, 2002·Biophysical Journal·Kevin J HallockA Ramamoorthy
Oct 11, 2002·The New England Journal of Medicine·Michael Zasloff
Feb 28, 2003·Expert Opinion on Investigational Drugs·Darren AbbanatKaren Bush
May 28, 2003·Biochemistry·Katherine A Henzler WildmanA Ramamoorthy
Jul 25, 2003·Antimicrobial Agents and Chemotherapy·Jared A SilvermanHoward M Shapiro
Apr 1, 1965·Bulletin of the Chemical Society of Japan·M FUJINOA MIYAKE
Apr 1, 1965·Bulletin of the Chemical Society of Japan·M FUJINO

❮ Previous
Next ❯

Citations

Oct 31, 2007·European Biophysics Journal : EBJ·Steven W HoSuzana K Straus
Mar 20, 2013·Journal of Industrial Microbiology & Biotechnology·Bassam AlkotainiAsmahani Azira Abdu Sani
Sep 3, 2010·Applied Biochemistry and Biotechnology·Wenyu LuQinggele Caiyin
Dec 16, 2009·International Journal of Antimicrobial Agents·Paolo A Grossi
Jun 6, 2007·Journal of Medicinal Chemistry·Qing Xiao, Dehua Pei
Dec 18, 2010·Nature Reviews. Microbiology·Julian G HurdleRichard E Lee
Apr 29, 2009·The Journal of Biological Chemistry·Artur SchmidtchenMartin Malmsten
Jun 5, 2010·The Journal of Biological Chemistry·Lars Robbel, Mohamed A Marahiel
Aug 2, 2008·The Journal of Antimicrobial Chemotherapy·Joanne Karen HobbsIan Chopra
Apr 6, 2011·Antimicrobial Agents and Chemotherapy·E RubinchikR E W Hancock
May 18, 2011·Antimicrobial Agents and Chemotherapy·Anne-K JohnRegine Landmann
Oct 1, 2008·Antimicrobial Agents and Chemotherapy·Ilana Lopes Baratella da Cunha CamargoKeiichi Hiramatsu
Sep 12, 2012·Antimicrobial Agents and Chemotherapy·Diana WolfThorsten Mascher
Jul 18, 2012·Antimicrobial Agents and Chemotherapy·Peter A Smith, Floyd E Romesberg
Oct 10, 2007·Antimicrobial Agents and Chemotherapy·Carmela T M MascioJared A Silverman
Jan 24, 2009·Antimicrobial Agents and Chemotherapy·Tina WeckeThorsten Mascher
Feb 25, 2009·Antimicrobial Agents and Chemotherapy·Griselda N SerranoFrank Schweizer
Jan 21, 2010·Antimicrobial Agents and Chemotherapy·Kien T NguyenRichard H Baltz
Jul 8, 2010·Antimicrobial Agents and Chemotherapy·Shaun P FalkBernard Weisblum
May 12, 2009·Applied and Environmental Microbiology·T BöttigerI Wiedemann
Jun 6, 2009·Future Microbiology·Slade O Jensen, Bruce R Lyon
Nov 26, 2013·World Journal of Microbiology & Biotechnology·Bassam AlkotainiAsmahani Azira Abdu Sani
Oct 15, 2013·International Journal of Medical Microbiology : IJMM·Tanja SchneiderHarald Gross
Feb 5, 2014·Marine Drugs·Fakir Shahidullah TareqHee Jae Shin
Jun 27, 2014·European Journal of Dentistry·Sofi Beaula WinfredGanesh Venkatraman
Feb 1, 2014·Chinese Journal of Integrative Medicine·Jayanta Kumar Patra, Yugal Kishore Mohanta
Aug 5, 2014·Biological & Pharmaceutical Bulletin·Hiroki KinouchiHiroshi Kamimori
Nov 5, 2013·Journal of Proteomics·Iosif VranakisGeorgios Tsiotis
Sep 5, 2013·Antimicrobial Agents and Chemotherapy·Soo-Jin YangArnold S Bayer
May 12, 2011·Cellular and Molecular Life Sciences : CMLS·Tomaz Koprivnjak, Andreas Peschel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.